滤泡性淋巴瘤的分子亚簇:来自英国血液系统恶性肿瘤研究网络的报告
该研究对英国血液系统恶性肿瘤研究网络中未经选择的548例滤泡性淋巴瘤患者进行293基因靶向测序,其中538例有完整临床随访(含96例弥漫大B细胞淋巴瘤转化),仅凭突变数据独立于易位状态解析出3个分子亚簇,并分析其与转化及生存的关系。
要点
- 仅凭突变数据可将滤泡性淋巴瘤分为FL_aSHM、FL_STAT6和FL_Com三个分子亚簇。
- FL_aSHM亚簇以异常体细胞超突变靶点高负荷为特征,FL_STAT6亚簇STAT6和CREBBP突变高、aSHM低。
- 26例有配对样本的转化病例中17例存在分支演化证据。
核心结论
- 该研究识别出与不同潜在机制通路相关的3个滤泡性淋巴瘤分子亚簇,这些亚簇可能通过纳入易位状态和更广泛突变谱进一步细分,对理解发病机制及未来改进治疗策略有启示。
研究设计与样本
- 基于人群的未经选择滤泡性淋巴瘤队列研究,采用293基因靶向测序,队列548例,其中538例有完整临床随访,包含96例弥漫大B细胞淋巴瘤转化。
主要发现
- 仅凭突变数据独立于易位状态解析出3个亚簇:FL_aSHM(异常体细胞超突变靶点高负荷)、FL_STAT6(STAT6和CREBBP突变高、aSHM低)、FL_Com(无其他亚型特征且KMT2D突变富集)。
- 突变特征分析显示亚组间预测突变特征富集不同,FL_aSHM亚组以G(C>T)T和G(C>T)C转换为主,符合既往定义的aSHM样模式。
- 26例有配对样本的转化病例中17例存在分支演化证据。
- aSHM组总生存较差(P = .04)与年龄较大相关,但整体肿瘤遗传学对预测个体患者风险提供的信息有限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular lymphoma (FL) is morphologically and clinically diverse, with mutations in epigenetic regulators alongside t(14;18) identified as disease-initiating events. Identification of additional mutational entities confirms this cancer's heterogeneity, but whether mutational data can be resolved into mechanistically distinct subsets remains an open question. Targeted sequencing was applied to an unselected population-based FL cohort (n = 548) with full clinical follow-up (n = 538), which included 96 diffuse large B-cell lymphoma (DLBCL) transformations. We investigated whether molecular subclusters of FL can be identified and whether mutational data provide predictive information relating to transformation. DNA extracted from FL samples was sequenced with a 293-gene panel representing genes frequently mutated in DLBCL and FL. Three clusters were resolved using mutational data alone, independent of translocation status: FL_aSHM, with high burden of aberrant somatic hypermutation (aSHM) targets; FL_STAT6, with high STAT6 & CREBBP mutation and low aSHM; and FL_Com, with the absence of features of other subtypes and enriched KMT2D mutation. Analysis of mutation signatures demonstrated differential enrichment of predicted mutation signatures between subgroups and a dominant preference in the FL_aSHM subgroup for G(C>T)T and G(C>T)C transitions consistent with previously defined aSHM-like patterns. Of transformed cases with paired samples, 17 of 26 had evidence of branching evolution. Poorer overall survival (OS) in the aSHM group (P = .04) was associated with older age; however, overall tumor genetics provided limited information to predict individual patient risk. Our approach identifies 3 molecular subclusters of FL linked to differences in underlying mechanistic pathways. These clusters, which may be further resolved by the inclusion of translocation status and wider mutation profiles, have implications for understanding pathogenesis as well as improving treatment strategies in the future.
引用
- Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network. Blood Adv. 2022. PMID: 35363872. doi:10.1182/bloodadvances.2021005284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。